🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of members share comparison images, injection guides and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering substances of uncertain source.

Some professionals said the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Removal

According to TikTok, the service has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for preparing or injecting at residence.

After moments of entering one group, a vendor shared contact information, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or past usage.

Product Information and Costs

Within these communities, posts display dark colored parcels with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how much time a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service stated it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the science behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered individuals harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may subject patients to potentially significant medical dangers”.